ONCOBIOLOGICS INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-21 | CoStar Group has room for expansion |  |
| 05-16 | Transcript : Outlook Therapeutics, Inc., Q2 2024 Earnings Call, May 16, 2024 |
Chart calendar Oncobiologics Inc
d6a1526f8a4012f9592d725e37edde6a._5wziNkCMHUdw_CHpVfBRTeZDUxROIRiRJjhlEVPzfk.kdhZvKFXWxpHupTX1SKbc2HqWSQEdNRRcqC7pRcti5impVzqt0gDTV-Plw~b465d15193d60cee7546bf48518331cd
Upcoming events on Oncobiologics Inc
Past events on Oncobiologics Inc
| 16/05/2024 13:30 | Q2 2024 Earnings Call |
| 15/05/2024 22:00 | Q2 2024 Earnings Release |
| 09/05/2024 13:10 | Retina World Congress |
| 04/05/2024 16:35 | OIS Retina Innovation Showcase |
| 07/03/2024 15:00 | Annual General Meeting |
| 14/02/2024 13:05 | Q1 2024 Earnings Release |
| 22/12/2023 13:05 | Q4 2023 Earnings Release |
| 07/11/2023 18:50 | Guggenheim Securities Inflammation & Immunology Conference |
| 26/09/2023 18:35 | Cantor Global Healthcare Conference |
| 13/09/2023 14:30 | H.C. Wainwright Global Investment Conference |
| 30/08/2023 13:30 | Business Update Call |
| 14/08/2023 13:05 | Q3 2023 Earnings Release |
| 07/08/2023 18:00 | BTIG Virtual Biotechnology Conference |
| 15/05/2023 13:05 | Q2 2023 Earnings Release |
| 02/05/2023 19:00 | H.C. Wainwright BioConnect Investor Conference |
| 29/03/2023 15:00 | Annual General Meeting |
| 14/02/2023 21:20 | SVB Securities Global Biopharma Conference |
| 14/02/2023 13:05 | Q1 2023 Earnings Release |
| 17/01/2023 16:00 | Virtual Investor Conference |
| 29/12/2022 14:05 | FY 2022 Earnings Release |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,15 2,91 180.2% | 0,00 0,13 - | 0,00 0,20 - | 0,00 0,00 - | 0,00 0,18 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -36,3 -31,2 -16.45% | -36,8 -37,3 1.17% | -51,7 -46,3 -11.61% | -63,1 -64,8 2.67% | -53,1 -56,2 5.44% | -67,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,9 -34,3 -10.65% | -38,5 -42,5 9.42% | -53,2 -47,9 -10.99% | -66,0 -67,4 2.06% | -59,0 -62,5 5.63% | -112 |
|
Net income Million USD | Released Forecast Spread | -36,0 -34,4 -4.7% | -48,9 -51,5 5.02% | -53,2 -48,0 -10.87% | -66,1 -66,8 1.11% | -59,0 -61,7 4.48% | -121 |
|
EPS USD | Released Forecast Spread | -39,6 -39,7 0.34% | -13,4 -16,8 20% | -7,00 -6,30 -11.11% | -6,20 -6,24 0.64% | -4,80 -4,86 1.18% | -5,60 |
| Announcement Date | 19/12/19 | 23/12/20 | 22/12/21 | 29/12/22 | 22/12/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,04 - | 0,00 0,18 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 1,65 | 1,95 | 2,25 |
|
EBIT Million USD | Released Forecast Spread | -18,9 -12,7 -49.18% | -17,0 -16,6 -2.32% | -14,0 -15,4 9.03% | -15,7 -17,3 9.44% | -6,84 -14,2 51.85% | -18,1 -11,9 -53.04% | -12,5 -15,5 19.61% | -10,3 -12,4 16.75% | -18,9 -16,9 -11.93% | -18,7 | -19,2 | -14,0 | -13,7 | -13,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,7 -13,5 -46.01% | -17,5 -17,3 -1.16% | -14,3 -17,0 15.75% | -18,7 -12,9 -44.69% | -6,65 -16,4 59.46% | -20,7 -14,1 -46.25% | -13,0 -16,6 21.84% | -11,2 -15,0 25.71% | -114 -18,4 -522.78% | -19,1 | -20,3 | -16,5 | -16,2 | -15,8 |
|
Net income Million USD | Released Forecast Spread | -19,7 -13,5 -46.02% | -17,5 -17,3 -1.16% | -14,3 -15,9 9.75% | -18,7 -12,9 -44.69% | -6,65 -15,4 56.8% | -20,7 -13,7 -50.61% | -13,0 -15,9 18.04% | -11,2 -15,0 25.71% | -114 -18,1 -531.17% | -19,5 | -20,4 | -16,5 | -16,2 | -15,8 |
|
EPS USD | Released Forecast Spread | -1,80 -1,27 -42.1% | -1,60 -1,47 -9.09% | -1,20 -1,35 11.11% | -1,60 -0,20 -700% | -0,60 -1,15 47.83% | -1,60 -1,03 -54.84% | -1,00 -1,14 12.5% | -0,80 -1,00 20% | -8,01 -0,91 -785.08% | -0,81 | -0,83 | -0,68 | -0,65 | -0,62 |
| Announcement Date | 13/05/22 | 10/08/22 | 29/12/22 | 14/02/23 | 15/05/23 | 14/08/23 | 22/12/23 | 14/02/24 | 15/05/24 | - | - | - | - | - |
| 30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Oncobiologics Inc
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 14/05/2024 12:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |
- Stock Market
- Equities
- OTLK Stock
- Stock
- Calendar Oncobiologics Inc
